Loading

Bi/Multispecific antibodies: challenges in translation [Topic TBC]

01 Dec 2025

15:50 - 16:50

Bi/Multispecifics

Industry Expert

Nisit Khandelwal, Chief Executive Officer & Co-Founder - Cycuria Therapeutics